Colorectal cancer (CRC) is the third most commonly diagnosed cancer globally and the
second cancer in terms of mortality. The prevalence of sarcopenia in patients with CRC …

Pancreatic ductal adenocarcinoma (PDAC) is associated with poor survival. Of all newly
diagnosed patients, only about 20% can benefit from a potentially curative surgical …

Background Special subtypes of pancreatic cancer, such as acinar cell carcinoma (ACC),
adenosquamous carcinoma (ASC), and anaplastic carcinoma of the pancreas (ACP), are …

Despite continued research, pancreatic ductal adenocarcinoma (PDAC) remains one of the
main causes of cancer death. Interest is growing in the role of the tumour suppressors breast …

Adenosquamous carcinoma of the pancreas (ASCP) is a very rare and highly aggressive
variant of pancreatic ductal adenocarcinoma, accounting for 0.5–4% of all pancreatic cancer …

Non-coding RNAs (ncRNAs), or RNA molecules that do not code for proteins, are generally
categorized as either small or long ncRNA (lncRNA) and are involved in the pathogenesis of …

Pancreatic cancer is an aggressive malignancy with increasing incidence. Pancreatic ductal
adenocarcinoma (PDAC) accounts for> 90% of pancreatic cancer diagnoses, while other …

Pancreatic cancer (PDAC) is one of the most aggressive solid tumors and is showing
increasing incidence. The aim of our review is to provide practical help for all clinical …

Pancreatic adenosquamous carcinoma (PASC) is a rare pathological subtype of pancreatic
cancer (PC), with a worse prognosis than pancreatic ductal adenocarcinoma (PDAC). Due …

Background The improved immunological understanding revealed the tumor
microenvironment as an appealing driver to restore the immune response against cancer …